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Clq PRECIPITIN IN THE SERA OF PATIENTS WITH ALLERGIC 
VASCULITIS (GOUGEROT-RUITER SYNDROME) 
SYED SHAFI ASGHAR, PH.D., WILLIAM R. FABER, M.D., AND R. H. CORMAN!!, M.D. 
Department of Dermatology, University of Amsterdam, Binnengasthuis,Amsterdam, The Netherlands 
The sera from two well-documented cases of allergic vasculitis were examined for the 
presence of Clq precipitins. Both sera contained material capable of precipitating Clq in 
agarose gel. The material from one of the sera was partially purified using ammonium sulfate 
precipitation, Sephadex G-200 filtration, and DEAE-cellulose chromatography. Attempts to 
identify the nature of Clq precipitin were unsuccessful, but it resembled the high-molecular-
weight precipitins of sera from patients with systemic lupus erythematosus. In a lesion, 
deposition of fibrinogen, immunoglobulins, and complement were noted mainly in the vessel 
walls. No correlation between immunoglobulin and complement deposition in the skin and 
the presence of C lq precipitins in the blood could be established. 
The Clq component of complement is known to 
precipitate soluble immune complexes [2], aggre-
gated -y-globulin [3], biologic polyanions such as 
DNA, meningococcal group A polysaccharides, 
and endotoxin polysaccharides [4,5 J. Several path-
ologic sera with strong C lq precipitins have been 
found to contain unidentified C lq reactants of 
varying molecular weights which appear to cause 
complement depression in vivo in certain instances 
[5]. The majority of these sera that react with Clq 
to give precipitin lines were from patients with 
systemic lupus erythematosus [3,5], leprosy {6,7], 
celiac disease, Crohn's disease and ulcerative co-
litis [8], and dermatitis herpetiformis [9J. The syn-
ovial fluid of patients with rheumatoid arthritis 
was also found to contain Clq precipitins [10]. 
In the course of a large-scale screening survey of 
sera from different diseases, the C lq-reactive ma-
terial was found in the sera of patients with allergic 
vasculitis. The disease is characterized by the pres· 
ence of fibrinoid necrosis of the small blood vessels 
with narrowing of the lumen, swelling of endothe-
lial cells. and accumulation of inflammatory infil-
trates around the affected blood vessels, with a pre-
dominance of neutrophils. Although neither the re-
sponsible antigens nor specific antibodies could be 
demonstrated, the presence of concomitant deposi-
tion of IgG and C3 in the damaged vascular walls 
with an absence of other serum constituents [11] 
suggest this disease to be an immune vasculitis. The 
present communication describes the presence of 
C lq-reactive material in the sera of patients with 
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allergic vasculitis and the results of the studies car-
ried out to understand its nature. 
MATERIALS AND METHODS 
The sera from two patients with allergic vasculitis were 
examined. The tests were also carried out on normal 
pooled serum from healthy volunteers. Extensive studies 
dealing with the characterization of C1q precipitin were 
performed on serum of patient P. This 67-year-old 
woman had severe allergic vasculitis with remissions and 
exacerbations for 21 years. 
Antisera. Rabbit antihuman CIq (batch no. KH 
43-1-1), horse antihuman IgA (PH 14-2-P8), rabbit an-
tihuman K-chain (KH 19-30-All, horse antihuman glob-
ulin (PH 17-4-P1), rabbit antihuman IgD (KH 20-5-AI), 
horse antihuman serum (PH 0-19-P2), horse antihuman 
IgM (PH 15-1-Pll), horse antihuman IgG (PH 16-4), 
rabbit antihuman BJX (KH 29-12-P02), rabbit antihu-
man a,-macroglobulin (KH 8-12), rabbit antihuman 
albumin (KH 2-13-1), normal rabbit serum, and normal 
horse serum were obtained from the Central Laboratories 
of the Red Cross Blood Transfusion Services, The Nether-
lands. 
Chemicals. Calf thymus deoxyribonucleic acid (DNA) 
was obtained from Worthington Biochemical Corporation 
and from Sigma Chemicals. DNA (E. coli) type VIII, 
DNase I (3100 Kunitz units/mg solid), RNA, trypsin type 
VITI, elastin powder, hyaluronic acid grade I, chondroitin 
sulfate type B, and olive oil substrate (Kit no. SOO) were 
obtained from Sigma Chemicals; RNllEe (45 Kunitz 
units/mg) and Pronase P from Sen'a; Pancreatin and 
pancreatic protease from Merck; and benzoyl arginine 
p-nitroanilide from Fluka. All the other cbemicals used 
were of analytical grade. 
The activities of trypsin, pancreatic protellEe, and 
Pancreatin (protease, lipase, and amylllEel were checked 
in our laboratory in order to be sure that their activities 
were not lost during storage. 
Trypsin was assayed by the method of Erlanger et al 
[12]. The enzyme released 0.8 }lmoles of nitroaniline per 
min per mg protein from benzoyl arginine nitroanilide 
(3.2 x 1O~' M) (pH 7.6) at 37"C. 
The activity of pancreatic protease was measured by 
estimating its caseinolytic activity. In a total volume of 
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0.5 ml, each assay contained 0.2 ml of 4% heat-denatured 
casein (65°C, 30 min), pH 7.5; 0.1 ml of 0.1 M sodium 
phosphate buffer, pH 7.5; and varying concentrations of 
enzyme. The tubes were incubated for I br at 37°C, 8 ml 
of 2.75% TCA was added, and the contents filtered. 
Under these conditions the enzyme hydrolyzed casein to 
produce color equivalent to 8.5 mmoles of tyrosine per hr 
per mg protein as estimated by the method of Lowry et al 
(13J. 
Protease activity in Pancreatin was assayed as de-
scribed above. It was found to contain an amount of 
protease which hydrolyzed casein to produce color equiv-
alent to 0.75 mmoles of tyrosine per hr per mg powder. 
Amylase activity in Pancreatin was assayed by the 
method of Close and Street [14]. The powder was found 
to contain 8.33 Street-Close units per mg solid. 
Lipase activity in Pancreatin was estimated by the 
method of Tietz et al [15]. The powder was found to 
contain 14 units per mg. One unit was defined as the 
number of ml of 0.05 N NaOH required to neutralize the 
free fatty acids liberated from olive oil substrate during 
the 6-hr incubation at pH B.O. 
DNase and RNase were considered active because 
preincubation of RNA and DNA with these enzymes 
under suitable conditions, as described later, abolished 
their property to give precipitin line against Clq. 
Cryoprecipitates. Cryoprecipitates were obtained from 
the serum at 4°C as described by Meltzer and Franklin 
(16] and used at a protein concentration of 10 mg per mL 
Preparation of insoluble antisera. The globulin frac-
tions of antisera to be solidified were isolated by ammo-
nium sulfate fractionation as described by Coons and 
Kaplan [17]. Two hundred milligrams of each isolated 
globulin were then insolubilized by the method described 
by Avrameas and Ternynck (18 J. The solidified antisera 
thus obtained were capable of removing specific globulin 
classes from normal serum or IgD-rich international 
reference serum. 
Preparation of C1q. Clq was isolated as described by 
Agnello et al (3]. Another preparation of highly purified 
Clq was obtained by the method ofYonemasu and Stoud 
(19]. 
Detection of Clq-reactive material by C 1q-precipita-
tion method. C Iq-reactive material was detected essen· 
tially by the metbod of Agnello et al [3]. Five·millimeter-
thick 0.6% agarose layers in veronal buffer, pH 7A, ionic 
strength 0.1, containing 0.01 M EDTA and O.ool % sodium 
azide were prepared. Wells were cut as described (3]. 
Unless mentioned otherwise, the central well contained 
Clq and the wells around it contained test material or 
serum. The plates were incubated at room temperature 
for 2 days. 
Estimation of C1 q level in the serum. Serum C lq levels 
were determined by the radial immunodiffusion method 
of Mancini et al [20]. A pooled serum of 250 healthy 
individuals served as a controL Using this pool as 
standard cont.rol, C Iq was also estimated in 54 individual 
normal serum samples to establish a baseline distribu-
tion and standard deviation of normal values. 
Estimation of serum hemolytic complement titer 
(CH50). The method used was a 4-ml modification of the 
7.5-ml assay of Kabat and Mayer [21 J. The incubation 
mixture in a total volume of 4.0 ml consisted of 7.6 x 10" 
sensitized sheep erythrocytes, isotonic veronal buffer, pH 
7.4, optimal concentrations of Mg+ + and Ca + +, and 
normal and patient serum in final dilutions ranging from 
1:125.9 to 1:316.2. Appropriate controls were included. 
The complement titer was obtained by plott.ing the log 
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Y!I- Y, where Y represents the degree of lysis, against the 
logarithm of final dilution of the serum. 
A pooled serum of 250 healthy individuals served as 
control. Using this pool as standard control, CH50 units 
were estimated in 52 individual normal serum samples to 
establish baseline of normal values, their distribution, and 
standard deviation. 
Elution characteristics of Clq-reactiue material on 
Sephadex G-200. One milliliter of patient serum was 
passed on a Sephadex G-200 column 0.6 x 84 em), 
preequilibrated with PBS at 4 DC. The column was run at 
a flow rate of I ml per 20 min and I-ml fractions were 
collected. The eluting solution was PBS. The fractions 
were tested for the presence of IgM (19S), ",-macro· 
globulin (19.6S), IgG (7S), and albumin (4S) by the 
micro-Ouchterlony technique using antiserum against 
these antigens to localize the marker proteins. 
Partial purification of Clq-reactive material. Ten 
milliliters of cryoglobulin-free patient serum were sub-
jected to 40-80% ammonium sulfate fractionation. The 
precipitate was dissolved in 1.5 ml of PBS and dialyzed 
against PBS at 4°C until all ammonium sulfate was 
removed. The dialyzed precipitate was applied to a 
Sephadex G-2oo column 11.6 x 82 cml, preequilibrated 
with PBS at 4°C. The column was run at a flow rate of 1 
ml per 16 min and 3.0-ml fractions were collected. The 
eluting solution was PBS. Two peaks of protein were 
obtained. The Clq·reactive material was localized in the 
first peak. This was concentrated and dialyzed against 
0.05 M NaCI in O.OO& M potassium phosphate buffer, pH 
7 .. 5. The dialyzed material in a volume of 3.7 ml was 
passed on a DEAE-cellulose column (1.6 x 20 em I, 
preequilibrated with 0.0& M :\aCl in 0.oo5 M pot.assium 
phosphate buffer, pH 7.5. The column was washed with 
100 ml of equilibrating buffer and then a linear gradient 
of NaCI was established using 0.75 M :\aCI in O.OO5 M 
potassium phosphate buffer, pH 'j .5. Two peaks were 
obtained and the Clq-reactive material appeared in the 
first peak at 0.12-0.16 M NaC! concentration. This peak 
was concentrated to 2.0 ml and was dialyzed against PBS 
before testing for Clq reactivity. 
Treatment of patient serum with various enzymes. In a 
total volume of 1.2 ml, the incubation mixture contained 
1 ml of pat.ient serum, 1 mg of Pronase P. and PBS, pH 
8.0. The contents were incubated at 37°C for 1 hr and 
dialyzed against PBS, pH 8.0, at room temperature for 24 
hr. Two sets of controls. one without Pronase and one 
without patient serum, were run simultaneously under 
similar conditions. 
Treatment with Pancreatin, pancreatic protease. and 
trypsin was carried out in a similar manner except that 
all the operations were done at pH 704. Treatment with 
2oo I"g of R~ ase was carried out at pH 7 A, with controls 
in which patient serum was replaced by PBS or 1 mg of 
RNA. 
For treatment of patient serum with DNase, the 
incubation mixture in a total volume of 1.2 ml contained 
I ml of serum, varying concentrations of DNase (2oo-600 
I"g), 10 mM Mg+', and PBS, pH 7.4. After incubation for 
1 hr at 37°C, the controls were dialyzed at room tempera-
ture against PBS containing 10 mM Mg H for 24 he 
Before testing Clq reactivity, Mg" was removed by 
further extensive dialysis against PBS alone. Controls 
were simultaneously run in which patient serum was 
replaced by PBS or 5oo }lg of calf thymus DNA, calf 
thymus nucleohistone, and E. coli DNA. 
Treatment of partially purified C 1 q-reactive materiol 
with various solidified antisera. Two-tenths of a milliliter 
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of partially purified Clq-reactive material was mixed in 
separate tubes with solidified globulin fractions of vari-
ous antisera. These included anti-IgG, anti-IgM, anti-
immunoglobulins, anti-lgD, anti-IgA, antihuman serum, 
anti-. chain, normal rabbit serum, and normal horse 
serum. The mixtures were stirred gently for 30 min at 
room temperature and then centrifuged. The supernatant 
fractions were kept cold and sediment regenerated as 
described by Avrameas and Ternynck (18). The superna-
tant fractions were then again stirred gently for 30 min at 
room temperature with the regenerated globulin fraction 
of the respective antisera. The contents were centrifuged 
and the supernatant tested for C1q reactivity in agarose 
gel plates. 
Reduction and alkylation. Reduction and alkylation of 
serum were carried out as described by Agnello et al [3], 
by incubation for 1 hr in 0.2 M 2-mercaptoethanol 
followed by treatment with a 1Mf excess of iodoaceta-
mide. The preparation was then dialyzed against 0.065 M 
veronal buffer, pH 8.6. DNA was similarly treated for 
comparison purposes. 
Estimation of protein. Protein was estimated by the 
method of Falin and Cio~aulteu as described by Lowry el 
al [13]. 
Immunofluorescence studies with skin biopsies. Biopsy 
samples were taken from skin lesions of patients with 
allergic vasculitis. Control biopsies were obtained from 
healthy individuals. The technique used has been de-
scribed previously by Cormane et al [22]. 
RESULTS 
Reactivity of Serum Samples with Clq 
Precipitin lines against C1q were obtained with 
sera of both patients with allergic vasculitis tested 
(Tab. I). Figure 1 shows the reactivitv of one of the 
patient's sera against Cl q in the a"garose geL A 
precipitin line was obtained with patient sera but 
not with pooled normal serum from 200 individu-
als. Anti-Clq (l unit/ml as estimated bv Beutner 
el al [23]) and DNA were also included i~ the test. 
Two different preparations of C lq, obtained by two 
different methods, having different degrees of pu-
nty, one of them almost homogeneous, gave simi-
lar results. This suggested that the interaction 
giving the precipitin line is due to C1q and is not 
an artifact due to impurities in C 1q preparations. 
The cryoglobulin present in one of the patient's 
sera did not give a precipitin line with Clq. The 
supernatant fraction after cryoprecipitation con-
tained material which could be precipitated by 
Clq in the agarose get. The Clq reactivity of 
TABLE I. Clq reactivity and complement levels in 
patients' sera 
Clq level Complement 
Sera Pabent Clq (t;.ofnor-
(CH501 
No. reacti\-"ity mal serum (S afnor-
pool) mal serum 1'0011 
1. P (Nov. 1972) positive 7 133 
2. P (March 1973) positive 66 89 
3. D positive 44 120 
Experimental conditions are described in the text. 
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. Fm. 1.. Agarose gel diffusion plate showing the precip-
ItatIOn of ISolated C1q. (1) Anti-C1q (J unit/m!); (2) DNA 
(200 Ilg/ml); (3) patient serum; (4) normal human serum· 
(5) Clq (500 -"g/ml). ' 
patient sera was abolished bv incubation at 56°C 
for 1 hr. • 
Clq Leuels in the Serum 
Because of the presence of C1q-reactive material 
in the patient sera, it was of interest to find out 
whether Clq binding took place in vivo, in which 
case the Clq levels in the blood would be low. In 
fact, during the active disease the C 1q levels 
fluctuated very much in one of the patients with 
whose serum considerable studies were done. In 
this serum, Clq level was 7t;( of normal value 
during the active disease, and 4 months later when 
she was still in the same condition, Clq level was 
66% of the normal value. A pool of serum from 250 
healthy individuals served as a standard control for 
Clq determinations. Fiftv-four normal serum sam-
ples were included which showed a mean value of 
98.4% of the normal pooled serum with a standard 
deviation of 14.9<;(. These results suggested a fairly 
good accuracy of the determinations and the suita-
bility of the pooled normal serum as controL If it is 
assumed that the pooled serum contained the 
reported normal value of 190 Itg per 100%, Clq 
levels in terms of Ilg per 100';; could be calculated. 
It will not be inappropriate to mention here that 
sera 1 (see Tab. I) which lacked Clq appreciably 
did not give a precipitin line against DNA, whereas 
sera 2 which contained appreciable amounts ofClq 
gave precipitin line against DNA (Fig. 2). Systemic 
lupus erythematosus (SLE) serum, giving precipi-
tin line against C1q but having normal Clq and 
CH50 units, gave a precipitin line against DNA 
and so did normal serum. 
CH50 Units in the Serum 
In spite of fluctuating levels of Clq in the patient 
sera, the CH50 remained normal. These results 
suggest that only small traces of C lq, perhaps by 
virtue of its ability to shift from one sensitized 
erythrocyte to another, might be enough to carry 
out hemolysis, The CH50 units, perhaps because of 
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FIG, 2. Agarose gel diffusion plate showing interaction 
between nucleic acid and Clq. (1) Normal serum; (2) 
patient serum (having 66% of normal Clq levell; (3) 
patient serum (having 7'7c of normal CIq level); (4) SLE 
serum (having CIq precipitins, normal CH50 units, and 
CIq level); (5) calf thymus DNA (1 mg/ml). Similar 
results were obtained with nucleohistone, E. coli and 
yeast RNA. 
this, remained unaffected by the presence of CIq-
reactive material or low Clq levels. 
A pool of serum from 250 healthy individuals 
served as standard control for CH50 determina-
tions. Fifty-two normal serum samples were in-
cluded which showed a mean value of 100.3':; of 
normal pooled serum with a standard deviation of 
16.49, . 
Elution Characteristics on Sephadex G-200 
'When whole serum of the patient was passed on 
Sephadex G-200, four peaks were obtained as 
shown in Figure 3. Clq-reactive material was 
localized in the peak in which a,-macroglobulin 
(l9.6S) and IgM (l9S) were detected using the 
appropriate antiserum. However, IgG and albumin 
peaks were free of Clq-reactive material. These 
results suggest that the material is a high-molecu-
lar-weight substance. 
Partial Purification of C Iq-reactive Material 
When serum after cryoprecipitation was frac-
tionated with ammonium sulfate and dialyzed, the 
Clq-reactive material appeared in the fractions 
between 40-80% ammonium sulfate saturation. 
This precipitate was passed on a Sephadex G-200 
column under the conditions described, and the 
CIq-reactive material appeared in the first protein 
peak (Fig. 4). The partially purified material thus 
obtained was stable for several weeks hut its 
further purification on DEAE-cellulose column 
(Fig. 5) rendered it highly unstable. Therefore, 
material obtained after Sephadex G-200 fractiona-
tion was used for further studies. A summary of the 
purification procedure is given in Table II. 
Attempt to Identify the Clq-reactive Material 
As is apparent from Figure 1, the lines obtained 
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TABLE ll. Isolation of Clq-reactive material from patient 
Pserum 
Vol. Total Clq Procedure protein (ml) (mg) reactivity 
Cryoglobulin-free sera 10 704 + 
40-80% Ammonium sulphate 1.5 309 + 
saturation 
Sephadex G-200 3.7 17 + 
DEAE-cellulose 2.0 1.32 + (highly 
unsta~le) 
Experimental conditions are described in the text. 
obtained with DNA against Clq. This raised the 
possibility that the Clq-reactive material might be 
DNA which leaked into the blood due to some 
unknown pathologic process. DNA content of the 
serum was therefore estimated by an isotope dilu-
tion technique and was found to be equal to that 
usually present in the normal serum_ When patient 
serum was alkylated and reduced, it lost its ability 
to give precipitin line with Clq, whereas DNA, 
when subjected to similar conditions, retained its 
reactivity against Clq. Furthermore, incubation of 
patient serum with DNase in presence of 10 mM 
Mg++ at pH 7.4 did not abolish Clq reactivity, but 
when calf thymus DNA, calf thymus nucleohis-
tone, and E. coli DNA were subjected to similar 
conditions they lost their ability to react with Clq. 
These results suggest that the Clq-reactive ma-
terial in patient serum is not DNA. 
Incubation of patient serum with RNase did not 
abolish Clq reactivity, but when RNA was sub-
jected to similar conditions it lost its ability to 
react with Clq. 
Incubation of patient serum with Pronase re-
sulted in the loss of Clq reactivity. However, 
Pancreatin, pancreatic protease, and trypsin had 
no effect. 
Clq did not give a precipitin line against hyalu-
ronic acid, chondroitin sulfate, and elastin, sug-
gesting that these polymers which might be ex-
pected to be released into blood because of patho-
logic process going on in the skin, are not identical 
to the Clq-reactive material. 
Partially purified preparations of C lq-reactive 
material obtained from Sephadex G-200 fractiona-
tion were contaminated with small amounts of IgG 
but when absorbed with solidified globulin fraction 
of horse antihuman IgG, they were free of IgG 
contamination, while still reacting with Clq. The 
preparation was free of detectable amounts of any 
other immunoglobulin. When treated with solidi-
fied globulin fractions of horse antihuman IgA, 
horse antihuman serum, rabbit antihuman K-
chain, rabbit antihuman globulin, rabbit antihu-
man IgD, horse antihuman IgM, horse antihuman 
IgG, normal rahhit serum, and normal horse se-
rum, the preparation did not lose Clq-reactive 
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material, thus reflecting doubt on the immune 
complex nature of Clq-reactive materiaL 
Attempts to identify the Clq-reactive material 
by immunoelectrophoresis were also unsuccessful. 
When Clq-reactive material from patient serum 
obtained by ammonium sulfate and Sephadex 
G-200 fractionation and similarly isolated fractions 
from normal serum were subjected to immunoelec-
trophoresis against antihuman serum, antihuman 
IgD, antihuman BJ", and antihuman K-chain, 
similar results were obtained. 
Histologic and Immunofluorescence Examination 
of the Skin 
A perivascular infiltrate composed of polymor-
phonuclear leukocytes and lymphocytes was pres-
ent, predominantly in the middle of the dermis. 
Nuclear fragmentation was observed. Depositions 
of fibrinogen and complement, including Clq, were 
noted mainly in the vessel walls and perivascular 
areas. At the onset of the disease, IgD and IgE 
deposits were seen in the perivascular areas and, at 
a later stage, IgM and IgA but not IgG deposits 
were observed in and around vessel walls and 
scattered throughout the dermis. 
Similar results were obtained with both pa-
tients. However, some other clinical, histologic, 
and immunologic findings with patient P have 
been described by Cormane et al [1]. 
DISCUSSION 
A variety of substances are known to be precipi-
tated by Clq under appropriate conditions. These 
include soluble immune complexes, aggregated 
,,-globulins, biologic polyanions, meningococcal 
group A polysaccharides, and endotoxin polysac-
charides. Besides this, Clq can precipitate certain 
unidentified materials in a variety of diseases 
[3,5,7-10]. The identities of Clq-reactive materials 
which have different molecular weights in different 
cases are unknown but they appear to have certain 
characteristics in common. Sometimes they are 
associated with depressed complement levels and 
are sensitive to reduction and alkylation and 
Pronase treatment. 
In the present study, high-molecular-weight ma-
terial capable of precipitating Clq present in the 
sera of patients with allergic vasculitis has been 
detected. The exact nature of the C1q reactant 
remains unknown but its presence appears closely 
related to the acute phase of the disease process in 
allergic vasculitis. Attempts to identify the mate-
rial did not throw light on its nature but it seems 
that DNA which can precipitate Clq is not in-
volved. It seems to resemble in its properties the 
Clq reactant of SLE sera [5] as regards its sensitiv-
ities to Pronase treatment and alkylation and 
reduction. The elimination of the reactivity of the 
sera with C1q after reduction and alkylation sug-
gests that the material might be aggregated or 
altered immunoglobulin but its inability to be 
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absorbed on solid anti-immunoglobulins reflects 
doubts on this possibility. Perhaps the material 
may represent a coprecipitant with other sub-
stances, which mayor may not be of foreign origin, 
constituting the main reactants. Studies are in 
progress to define this reactant. 
The presence of various immunoglobulin de-
posits and complement including Clq in and 
around the vessel wall and accumulation of poly-
morphonuclear leukocytes in the skin biopsies of 
patients has been confirmed. This suggests that 
the disease is immunologic and possibly Arthus 
type reaction might be taking place in patient skin. 
However, because of the failure to demonstrate the 
immune complex nature of Clq precipitin, the 
interrelationship between immune deposits and 
circulating Clq precipitins remains unclear. 
The authors are greatly indebted to Miss Marianne 
Spillekom for her skillful technical assistance. 
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